# Cocrystal Pharma, Inc. (COCP)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/COCP/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 330.0K | $ -5.46M | $ -4.86M | $ 1.34M | $ 1.04M |
| 2025 | $ 0 | $ -9.04M | $ -8.59M | $ 1.51M | $ 6.33M |
| 2024 | $ 0 | $ -18.40M | $ -17.34M | $ 1.81M | $ 9.52M |
| 2023 | $ 0 | $ -19.45M | $ -15.99M | $ 1.85M | $ 26.38M |
| 2022 | $ 0 | $ -43.39M | $ -24.03M | $ 297.0K | $ 39.57M |
| 2021 | $ 0 | $ -16.86M | $ -15.18M | $ 534.0K | $ 77.55M |
| 2020 | $ 2.57M | $ -12.29M | $ -12.83M | $ 596.0K | $ 52.51M |
| 2019 | $ 8.47M | $ -62.17M | $ -2.20M | $ 817.0K | $ 25.71M |
| 2018 | $ 0 | $ -64.78M | $ -10.99M | $ 331.0K | $ 66.89M |
| 2017 | $ 0 | $ -825.8K | $ -9.30M | $ 1.01M | $ 105.40M |
| 2016 | $ 0 | $ -103.01M | $ -20.23M | $ 0 | $ 102.32M |
| 2015 | $ 0 | $ -70.37M | $ -14.96M | $ 0 | $ 167.59M |
| 2014 | $ 12.7K | $ -138.5K | $ -8.49M | $ 0 | $ 6.65M |
| 2013 | $ 437.7K | $ -27.91M | $ -6.50M | $ 2.87M | $ -6.03M |
| 2012 | $ 24.82M | $ -13.14M | $ -2.66M | $ 5.65M | $ -3.58M |
| 2011 | $ 19.05M | $ -7.23M | $ -1.51M | $ 6.45M | $ -2.77M |
| 2010 | $ 11.59M | $ -73.4K | $ -570.8K | $ 6.90M | $ 10.5K |
| 2009 | $ 0 | $ -62.6K | $ -38.0K | $ 0 | $ 57.1K |
| 2008 | $ 0 | $ -80.1K | $ -50.8K | $ 0 | $ 96.7K |
| 2007 | $ 0 | $ -81.3K | $ -49.8K | $ 0 | $ 147.8K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 1.28 |
| Liabilities / Eq | 3.45 |
| Current Ratio | 1.24 |

## Other views

- [Metrics](https://sponda.capital/en/COCP.md)
- [Charts](https://sponda.capital/en/COCP/charts.md)
- [Compare](https://sponda.capital/en/COCP/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.